Hand-foot syndrome (chemotherapy)
Updates to Article Attributes
Body
was changed:
Hand-foot syndrome, also known as palmar-plantar erythrodysesthesia or Burgdorf reaction, is is a benign aseptic self-limiting complication of many chemotherapeutic agents characterised by a widespread erythema, oedema and ulceration of the hands and feet.
Causative drugs
Many chemotherapeutic agents have been described as causing hand-foot syndrome including 1:
- 5-fluorouracil
- capecitabine
- cyclophosphamide
- cytarabine
- docetaxel
- etoposide
- hydroxyurea
- liposomal doxorubicin
- mercaptopurine
- methotrexate
- paclitaxel
- sorafenib
- sunitinib
- tegafur
- vinorelbine
Disambiguation
Hand-foot syndrome in the setting of chemotherapy should not be confused with:
-<p><strong>Hand-foot syndrome</strong>, also known as <strong>palmar-plantar erythrodysesthesia</strong> or <strong>Burgdorf reaction</strong>, is a benign aseptic self-limiting complication of many chemotherapeutic agents characterised by a widespread erythema, oedema and ulceration of the hands and feet. </p><h4>Causative drugs</h4><p>Many chemotherapeutic agents have been described as causing hand-foot syndrome including <sup>1</sup>: </p><ul>- +<p><strong>Hand-foot syndrome</strong>, also known as <strong>palmar-plantar erythrodysesthesia</strong> or <strong>Burgdorf reaction</strong>, is a benign aseptic self-limiting complication of many chemotherapeutic agents characterised by a widespread erythema, oedema and ulceration of the hands and feet. </p><h4>Causative drugs</h4><p>Many chemotherapeutic agents have been described as causing hand-foot syndrome including <sup>1</sup>: </p><ul>
Unable to process the form. Check for errors and try again.